121 related articles for article (PubMed ID: 20207503)
1. Brachytherapy in the treatment of cholangiocarcinoma.
Shinohara ET; Guo M; Mitra N; Metz JM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):722-8. PubMed ID: 20207503
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas.
Shinohara ET; Mitra N; Guo M; Metz JM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1191-8. PubMed ID: 19201549
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
[TBL] [Abstract][Full Text] [Related]
4. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.
Gerhards MF; van Gulik TM; González González D; Rauws EA; Gouma DJ
World J Surg; 2003 Feb; 27(2):173-9. PubMed ID: 12616432
[TBL] [Abstract][Full Text] [Related]
5. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of intrahepatic cholangiocarcinoma--a population-based study.
Tan JC; Coburn NG; Baxter NN; Kiss A; Law CH
Ann Surg Oncol; 2008 Feb; 15(2):600-8. PubMed ID: 17987347
[TBL] [Abstract][Full Text] [Related]
7. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
[TBL] [Abstract][Full Text] [Related]
8. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.
Shaib YH; Davila JA; Henderson L; McGlynn KA; El-Serag HB
J Clin Gastroenterol; 2007; 41(10):911-7. PubMed ID: 18090160
[TBL] [Abstract][Full Text] [Related]
10. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
Ben-David MA; Griffith KA; Abu-Isa E; Lawrence TS; Knol J; Zalupski M; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):772-9. PubMed ID: 17011452
[TBL] [Abstract][Full Text] [Related]
11. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
[TBL] [Abstract][Full Text] [Related]
12. Hepatic portal cholangiocarcinoma: a clinical analysis of 70 cases.
Zhang HY; Kong YL; Zhang HY; He XJ; Zhang H; Liu CL; Zhao G; Xiao M; Zhang XD; Feng ZQ
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):418-21. PubMed ID: 18693179
[TBL] [Abstract][Full Text] [Related]
13. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for unresectable perihilar cholangiocarcinoma.
Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Nyberg SL; Ishitani MB; Rosen CB
Semin Liver Dis; 2004 May; 24(2):201-7. PubMed ID: 15192792
[TBL] [Abstract][Full Text] [Related]
16. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
Singal AG; Rakoski MO; Salgia R; Pelletier S; Welling TH; Fontana RJ; Lok AS; Marrero JA
Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
18. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of surgical approach for extrahepatic cholangiocarcinoma.
Shi QF; Liang TB; Qin YS; Wang WL; Shen Y; Zhang M; Zheng SS
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):622-6. PubMed ID: 18086629
[TBL] [Abstract][Full Text] [Related]
20. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
